NovaBridge Biosciences Revenue from Contract with Customer, Excluding Assessed Tax
NovaBridge Biosciences (NBP) reported Revenue from Contract with Customer, Excluding Assessed Tax of CNY 51.86 million for the 6-month period ending 2022-06-30, per its 6-K filed 2022-11-10.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2022-11-10
- NovaBridge Biosciences revenue from contract with customer, excluding assessed tax for the quarter ending 2019-12-31 was 0.00 CNY.
CNY
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2022-06-30 | 51.86M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 88.03M CNY 20-F · filed 2022-04-29 | |||
| 2021-06-30 | 17.77M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 1.54B CNY 20-F · filed 2022-04-29 | |||
| 2019-12-31 | 0.00 CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 30.00M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 30.00M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 53.78M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | 11.56M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|
| 2022-06-30 | $7.74M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $13.81M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $236.42M 20-F · filed 2021-04-28 | |
| 2019-12-31 | $4.31M 20-F · filed 2020-04-29 |